loadpatents
name:-0.017882108688354
name:-0.010082006454468
name:-0.0066120624542236
Graffner; Hans Patent Filings

Graffner; Hans

Patent Applications and Registrations

Patent applications and USPTO patent grants for Graffner; Hans.The latest application filed is for "ibat inhibitors for the treatment of liver diseases".

Company Profile
5.9.19
  • Graffner; Hans - Helsingborg SE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
IBAT inhibitors for the treatment of liver diseases
Grant 11,261,212 - Gillberg , et al. March 1, 2
2022-03-01
Ibat Inhibitors For The Treatment Of Liver Diseases
App 20210340175 - Gillberg; Per-Goran ;   et al.
2021-11-04
IBAT inhibitors for the treatment of liver diseases
Grant 10,981,952 - Gillberg , et al. April 20, 2
2021-04-20
Pharmaceutical Combination Comprising An Ibat Inhibitor And A Bile Acid Binder
App 20200330545 - Gillberg; Per-Goran ;   et al.
2020-10-22
Ibat Inhibitors For The Treatment Of Liver Diseases
App 20200140484 - Gillberg; Per-Goran ;   et al.
2020-05-07
IBAT inhibitors for the treatment of liver diseases
Grant 10,487,111 - Gillberg , et al. Nov
2019-11-26
IBAT inhibitors for the treatment of liver diseases
Grant 10,221,212 - Gillberg , et al.
2019-03-05
Ibat Inhibitors For The Treatment Of Liver Diseases
App 20180362577 - Gillberg; Per-Goran ;   et al.
2018-12-20
IBAT inhibitors for the treatment of liver diseases
Grant 10,093,697 - Gillberg , et al. October 9, 2
2018-10-09
IBAT inhibitors for the treatment of liver diseases
Grant 10,011,633 - Gillberg , et al. July 3, 2
2018-07-03
IBAT inhibitors for the treatment of liver diseases
Grant 10,000,528 - Gillberg , et al. June 19, 2
2018-06-19
Ibat Inhibitors For The Treatment Of Liver Diseases
App 20180162904 - Gillberg; Per-Goran ;   et al.
2018-06-14
Ibat Inhibitors For The Treatment Of Liver Diseases
App 20180030088 - Gillberg; Per-Goran ;   et al.
2018-02-01
Ibat Inhibitors For The Treatment Of Liver Diseases
App 20180030089 - Gillberg; Per-Goran ;   et al.
2018-02-01
Ibat Inhibitors For The Treatment Of Liver Diseases
App 20180022776 - Gillberg; Per-Goran ;   et al.
2018-01-25
IBAT inhibitors for the treatment of liver disease
Grant 9,694,018 - Gillberg , et al. July 4, 2
2017-07-04
IBAT Inhibitors for the Treatment of Liver Disease
App 20170182059 - Gillberg; Per-Goran ;   et al.
2017-06-29
Pharmaceutical Combination Comprising An Ibat Inhibitor And A Bile Acid Binder
App 20170182115 - Gillberg; Per-Goran ;   et al.
2017-06-29
IBAT inhibitors for the treatment of liver diseases
Grant 9,688,720 - Gillberg , et al. June 27, 2
2017-06-27
Ibat Inhibitors For The Treatment Of Liver Diseases
App 20160193277 - Gillberg; Per-Goran ;   et al.
2016-07-07
Ibat Inhibitors For The Treatment Of Liver Diseases
App 20160194353 - Gillberg; Per-Goran ;   et al.
2016-07-07
Ibat Inhibitors For The Treatment Of Liver Diseases
App 20150031636 - Gillberg; Per-Goran ;   et al.
2015-01-29
Pharmaceutical Combination Comprising An Ibat Inhibitor And A Bile Acid Binder
App 20150031637 - Gillberg; Per-Goran ;   et al.
2015-01-29
Pharmaceutical Combination Comprising An Ibat Inhibitor And A Bile Acid Binder
App 20130236541 - Gillberg; Per-Goran ;   et al.
2013-09-12
Ibat Inhibitors For The Treatment Of Liver Diseases
App 20130225511 - Gillberg; Per-Goran ;   et al.
2013-08-29
Ibat Inhibitors For Treatment Of Metabolic Disorders And Related Conditions
App 20120114588 - Starke; Ingemar ;   et al.
2012-05-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed